ANAPSINASE
LIVE

Serial Number

79331716

Owner

CRISTALFARMA S.r.l.

Attorney

John Zaccaria

Filing Date

Nov 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ANAPSINASE Trademark

Serial Number: 79331716 • Registration: 7045399

ANAPSINASE is a trademark filed by CRISTALFARMA S.r.l. on November 22, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CRISTALFARMA S.r.l. (32 trademarks)

Via S. G. Cottolengo 15

Entity Type: 16

Trademark Details

Filing Date

November 22, 2021

Registration Date

May 9, 2023

Published for Opposition

February 21, 2023

Goods & Services

Industrial chemicals; chemical substances for preserving foodstuffs; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes

Pharmaceuticals for the treatment of neurological conditions sold as a component ingredient of a food and dietary supplement; phytotherapy preparations for medical purposes for the treatment of neurological conditions sold as a component ingredient of a food and dietary supplement; chemico-pharmaceutical preparations for the treatment of neurological conditions sold as a component ingredient of a food and dietary supplement; nutraceutical preparations for therapeutic or medical purposes for the treatment of neurological conditions sold as a component ingredient of a food and dietary supplement; plant extracts for pharmaceutical purposes sold as a component ingredient of a food and dietary supplement; dietary fibre to aid in digestion sold as a component ingredient of a food and dietary supplement; vitamin preparations sold as a component ingredient of a food and dietary supplement; medicinal roots sold as a component ingredient of a food and dietary supplement

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 5, 2026 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 4, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 14, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 14, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 9, 2023 FICR
REGISTERED-PRINCIPAL REGISTER
May 9, 2023 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 9, 2023 NRCC
NOTIFICATION PROCESSED BY IB
Feb 21, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 21, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 1, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 1, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 13, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 13, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 13, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 13, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 13, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 13, 2023 COAR
REFUSAL PROCESSED BY IB
Dec 5, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 16, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 9, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Mar 18, 2022 NREP
APPLICATION FILING RECEIPT MAILED
Feb 1, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 27, 2022 REPR